Advertisement

Premalignant Lesions of the Oesophagus: Identification to Management

  • Andrew Latchford
  • Janusz A.Z. Jankowski
Part of the Springer Specialist Surgery Series book series (SPECIALIST)

Keywords

Bile Acid Methylene Blue Human Papilloma Virus Intestinal Metaplasia Endoscopic Mucosal Resection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cameron AJ, Lomboy CT Pera M et al. Adenocarcinoma of oesophagogastric junction and Barrett’s oesophagus. Gastroenterology 1992;103(4):1241–45.PubMedGoogle Scholar
  2. 2.
    Jankowski J, Harrison R, Perry I et al. Barrett’s metaplasia. Lancet 2000;356:2079–85.CrossRefPubMedGoogle Scholar
  3. 3.
    Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212–15.PubMedGoogle Scholar
  4. 4.
    Poynton AR, Walsh TN, O’Sullivan G, Hennessy TPJ. Carcinoma arising in familial Barrett’s esophagus. Am J Gastroenterol 1996;91:1855–6.PubMedGoogle Scholar
  5. 5.
    Jankowski J, Hopwood D, Pringle R, Wormsley K. Increased expression of EGFR in Barrett’s esophagus associated with alkaline reflux: a putative model for carcinogenesis. Am J Gastroenterol 1993;56:1480–3.Google Scholar
  6. 6.
    Klump B, Hsieh CJ, Holzman K et al. Hypermethylation of the CDKNZ/p16 promoter during neoplastic progression of Barrett’s esophagus. Gastroenterology 1998;115:1381–86.PubMedGoogle Scholar
  7. 7.
    Wong DJ, Barrett MT, Stoger R et al. p16/NK4a promoter is hypermethylated at a higher frequency in esophageal adenocarcinoma. Cancer Res 1997;57:2619–22.PubMedGoogle Scholar
  8. 8.
    Morales CP, Lee EL, Shay JW. In situ hybridisation for the detection of telomerase RNA in the progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer 1998;83:652–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Reid BJ, Haggitt RC, Rubin CE et al. Flow-cytometric and histological progression to malignancy in Barrett’s esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212–19.PubMedGoogle Scholar
  10. 10.
    Richards FM, McKee SA, Rajpar MH et al. Germ-line Ecadherin gene (CDH1) mutations predispose to familial gastric and colorectal cancer. Hum Mol Genet 1999;4:607–10.CrossRefGoogle Scholar
  11. 11.
    Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995;76:1116–19.PubMedGoogle Scholar
  12. 12.
    Thun MJ, Namboodiuri MM, Calle EE et al. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322–27.PubMedGoogle Scholar
  13. 13.
    Edwards MJ, Gable DR, Lentsch AB et al. The rationale for oesophagectomy as the optimal therapy for Barrett’s oesophagus with high-grade dysplasia. Ann Surg 1996;223(5):585–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Canto MI, Setrakian S, Willis J et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gatsrointest Endosc 2000;51(5):560–8.CrossRefGoogle Scholar
  15. 15.
    Endlicher E, Knuechel R, Hauser T et al. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett’s oesophagus using systemic or local 5-aminolaevulinic acid sensitisation Gut 2001;48:314–319.CrossRefPubMedGoogle Scholar
  16. 16.
    Muto M, Hitomi Y, Ohtsu A et al. Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophagea dysplasia in head and neck cancer patients. Gut 2000;47(2):256–61.CrossRefPubMedGoogle Scholar
  17. 17.
    Itakura Y, Sasano F, Date F et al. DNA ploidy, p53 expression and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi. Anticancer Res 1996;16(1):201–8.PubMedGoogle Scholar
  18. 18.
    Sanders DS, Bruton R, Darnton SJ et al. Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. Int J Cancer 1998;79(6):573–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Jenkins TD, Mueller A, Odze R et al. Cyclin D1 overex-pression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium. Oncogene 1999;18(1):59–66.CrossRefPubMedGoogle Scholar
  20. 20.
    Sibble A, Lambert R, Souquet JC et al. Long-term survival after PDT for esophageal cancer. Gastroenterology 1995;108:337–46.CrossRefPubMedGoogle Scholar
  21. 21.
    Risk JM, Whittaker J, Fryer A et al. Tylosis oesophageal cancer mapped. Nat Genet 1994;8:319–21.CrossRefPubMedGoogle Scholar
  22. 22.
    Odze R, Antonioli D, Shocket D et al. Esophageal squamous papillomas. A clinicopathologic study of 38 lesions and analysis for human papilloma virus by the polymerase chain reaction. Am J Surg Pathol 1993;17(8):803–12.PubMedGoogle Scholar
  23. 23.
    Orlowska J, Jarosz D, Gugulski A et al. Squamous cell papillomas of the esophagus: Report of 20 cases and literature review. Am J Gastroenterol 1994;89(3):319–21PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2005

Authors and Affiliations

  • Andrew Latchford
  • Janusz A.Z. Jankowski

There are no affiliations available

Personalised recommendations